← All organizations
Nordic Bioscience
For profitWebsite ↗
Also known as: Aditech Pharma AB | NBCD A/S | Nordic Bioscience A/S | Nordic Bioscience Clinical Development | Nordic Bioscience Clinical Development (NBCD) | Nordic Bioscience Clinical Studies A/S | Nordic Biotic Sp. z o.o. | Rheoscience A/S
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2004Last known activity
Dec 1, 2025
Timeline
1990s
- Jan 1, 1991
Nordic Bioscience— Founded
Drugs by trial phase (24 distinct, 27 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (36)
- NCT07276009Lead sponsorN/ADec 1, 2025
- NCT06693648CollaboratorPhase 3Jan 31, 2025
- NCT06671054CollaboratorPhase 2Oct 1, 2024
- NCT06233474CollaboratorPhase 1/Phase 2Jan 26, 2024
- NCT05796765CollaboratorPhase 2Feb 17, 2023
- NCT05604885CollaboratorPhase 2Nov 30, 2022
- NCT05603754CollaboratorPhase 3Nov 18, 2022
- NCT05618782CollaboratorPhase 2Oct 17, 2022
- NCT05516979CollaboratorPhase 2Sep 26, 2022
- NCT05100225CollaboratorPhase 2Sep 30, 2021
- NCT05064930Lead sponsorN/ASep 1, 2021
- NCT05064930Reponsible party - principal investigatorN/ASep 1, 2021
- NCT05013060Reponsible party - principal investigatorN/AApr 15, 2021
- NCT05013060Lead sponsorN/AApr 15, 2021
- NCT04657926Study directorPhase 2Sep 9, 2020
Details
- Founded
- Herlev, DK Jan 1, 1991
- Last known activity
- Dec 1, 2025